Design, synthesis and biological evaluation of quinazoline–phosphoramidate mustard conjugates as anticancer drugs-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Design, synthesis and biological evaluation of quinazoline–phosphoramidate mustard conjugates as anticancer drugs

Published:2017-02 Issue: Volume:127 Page:442-458
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Lin Songwen,Li Yingbo,Zheng Yufen,Luo Laichun,Sun Qi,Ge Zemei,Cheng Tieming,Li Runtao

Funder

Ministry of Science and Technology of China

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference61 articles.

1. The ERBB network: at last, cancer therapy meets systems biology;Yarden;Nat. Rev. Cancer,2012

2. Lapatinib plus capecitabine for HER2-positive advanced breast cancer;Geyer;N. Engl. J. Med.,2006

3. Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells;Konecny;Cancer Res.,2006

4. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma;Mok;N. Engl. J. Med.,2009

5. National Cancer Institute of Canada Clinical Trials Group; Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada clinical trials group;Moore;J. Clin. Oncol.,2007

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the future: Innovative design strategies and emerging challenges in HER2-targeted tyrosine kinase inhibitors for cancer therapy;European Journal of Medicinal Chemistry;2024-10

2. 6-Bromo quinazoline derivatives as cytotoxic agents: design, synthesis, molecular docking and MD simulation;BMC Chemistry;2024-07-04

3. Continuous Flow Synthesis of a Key Intermediate Common to Gefitinib and Larotinib;Organic Process Research & Development;2024-02-20

4. Recent Advances in Structural Modification Strategies for Lead Optimization of Tyrosine Kinase Inhibitors to Explore Novel Anticancer Agents;Current Medicinal Chemistry;2023-07

5. Synthesis and In-vitro Biological Analyses of New quinazolin-2,4-dione Derivatives;Egyptian Journal of Chemistry;2022-01-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3